UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 25, 2026
Sale
Calculated transaction value
$669.92K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 24, 2026
Public filing date
Aug 25, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$512.88
Aug 24, 2026
Close before public filing
$512.88
Aug 24, 2026
Return since public filing
-3.07%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,305 shares @ $513.35
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000127
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$6.15M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 24, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 24, 2026 | $114.11K |
| United Therapeutics Corp UTHR | Sale | Aug 24, 2026 | $675.42K |
| United Therapeutics Corp UTHR | Sale | Aug 24, 2026 | $1.56M |
| United Therapeutics Corp UTHR | Sale | Aug 24, 2026 | $1.84M |
| United Therapeutics Corp UTHR Current | Sale | Aug 24, 2026 | $669.92K |
| United Therapeutics Corp UTHR | Exercise | Aug 24, 2026 | $0 |